rs137854607
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000335.5(SCN5A):āc.4780G>Cā(p.Asp1594His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1594N) has been classified as Pathogenic.
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.4783G>C | p.Asp1595His | missense_variant | 27/28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.4780G>C | p.Asp1594His | missense_variant | 27/28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.4783G>C | p.Asp1595His | missense_variant | 27/28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.4780G>C | p.Asp1594His | missense_variant | 27/28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460662Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726404
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2023 | Published functional studies demonstrate a damaging effect on sodium channel function (Nguyen et al., 2008); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22581653, 15671429, 18048769) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 1595 of the SCN5A protein (p.Asp1595His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of dilated cardiomyopathy (PMID: 15671429). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 9406). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN5A function (PMID: 18048769). This variant disrupts the p.Asp1595 amino acid residue in SCN5A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11804990; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Dilated cardiomyopathy 1E Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 26, 2005 | - - |
Long QT syndrome 3;C4551804:Brugada syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | Dec 31, 2019 | This c.4783G>C (p.Asp1595His) variant in SCN5A gene results in an amino acid change at residue 1595 from an aspartic acid to a histidine. This variant has been reported to cosegregate with dilated cardiomyopathy in a family (PMID: 15671429). It is absent from the general population database gnomAD. A different variant at the same codon c.4783G>A (p.Asp1595Asn) has been classified as pathogenic/likely pathogenic (ClinVar accession: VCV000009385.1). In vitro functional studies at amino acid position 1595 indicate that both p.Asp1595His (PMID: 18048769) and p.Asp1595Asn (PMID: 11804990) impair sodium channel function. Multiple lines of in silico algorithms predict the c.4783G>C (p.Asp1595His) variant to be deleterious. Based on the currently available evidence, we consider the variant c.4783G>C (p.Asp1595His) of SCN5A to be likely pathogenic. - |
Primary dilated cardiomyopathy Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Dilated cardiomyopathy in the following publications (PMID:15671429;PMID:18048769). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at